Giant Biogene Holding Co (HKSE:02367) Price-to-Owner-Earnings : 30.63 (As of May. 23, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Giant Biogene Holding Co Price-to-Owner-Earnings?

As of today (2024-05-23), Giant Biogene Holding Co's share price is HK$51.15. Giant Biogene Holding Co's Owner Earnings per Share (TTM) ended in Dec. 2023 was HK$1.67. It's Price-to-Owner-Earnings for today is 30.63.

The historical rank and industry rank for Giant Biogene Holding Co's Price-to-Owner-Earnings or its related term are showing as below:

HKSE:02367' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 18.7 Med: 24.84 Max: 31.45
Current: 30.67

During the past 5 years, the highest Price-to-Owner-Earnings of Giant Biogene Holding Co was 31.45. The lowest was 18.70. And the median was 24.84.

HKSE:02367's Price-to-Owner-Earnings is ranked worse than
72.86% of 925 companies
in the Consumer Packaged Goods industry
Industry Median: 14.97 vs HKSE:02367: 30.67

As of today (2024-05-23), Giant Biogene Holding Co's share price is HK$51.15. Giant Biogene Holding Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.62. Therefore, Giant Biogene Holding Co's PE Ratio for today is 31.59.

As of today (2024-05-23), Giant Biogene Holding Co's share price is HK$51.15. Giant Biogene Holding Co's EPS without NRI for the trailing twelve months (TTM) ended in was HK$1.59. Therefore, Giant Biogene Holding Co's PE Ratio without NRI for today is 32.13.

During the past 5 years, Giant Biogene Holding Co's highest PE Ratio without NRI was 52.72. The lowest was 19.64. And the median was 31.55.

Giant Biogene Holding Co Price-to-Owner-Earnings Historical Data

The historical data trend for Giant Biogene Holding Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Giant Biogene Holding Co Price-to-Owner-Earnings Chart

Giant Biogene Holding Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Owner-Earnings

21.30

Giant Biogene Holding Co Semi-Annual Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Owner-Earnings	Get a 7-Day Free Trial			-	-	-	-	21.30

Competitive Comparison of Giant Biogene Holding Co's Price-to-Owner-Earnings

For the Household & Personal Products subindustry, Giant Biogene Holding Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Giant Biogene Holding Co's Price-to-Owner-Earnings Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Giant Biogene Holding Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Giant Biogene Holding Co's Price-to-Owner-Earnings falls into.

Giant Biogene Holding Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Giant Biogene Holding Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings	=	Share Price	/	Owner Earnings per Share (TTM)
	=	51.15	/	1.67
	=	30.63

Giant Biogene Holding Co (HKSE:02367) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.

Giant Biogene Holding Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Giant Biogene Holding Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.

Giant Biogene Holding Co (HKSE:02367) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Giant Biogene Holding Co Ltd (HKSE:02367) » Definitions » Price-to-Owner-Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1855, Shanglin Yuan 7th Road, Chang’an District, Shaanxi Province, Xi’an, CHN

Website

http://www.xajuzi.com

Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.

Giant Biogene Holding Co (HKSE:02367) Headlines

No Headlines